The Neoadjuvant Administration of PD-1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous-Cell Carcinoma

Table 3

Surgical information and pathological response.

Items	Locally advanced ESCC patients (N = 25)
Surgical information, no. (%)
Tumor resection rate	25 (100.0)
R0 resection rate	24 (96.0)
TRG system, no. (%)
TRG1	13 (52.0)
TRG2	5 (20.0)
TRG3	6 (24.0)
TRG4	1 (4.0)
pCR, no. (%)
Yes	13 (52.0)
No	12 (48.0)

ESCC, esophageal squamous-cell carcinoma; TRG, tumor regression grade; pCR, pathological complete response.